Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Govt recovered just 12...

    Govt recovered just 12 percent of Rs 4,959 crore drug overcharging fine

    Written by supriya kashyap kashyap Published On 2016-11-23T11:07:16+05:30  |  Updated On 23 Nov 2016 11:07 AM IST
    Govt recovered just 12 percent of Rs 4,959 crore drug overcharging fine

    New Delhi : The government has been able to recover only Rs 598.81 crore, which is just about 12 per cent of the total fine worth Rs 4,958.74 crore slapped on drug firms for overcharging.


    "Since inception of National Pharmaceutical Pricing Authority (NPPA), 1,467 demand notices as on October 31, 2016 have been issued to the companies for their overcharging the consumers on the sale of medicines," Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said in a written reply to the Lok Sabha.


    Of the total, about 1,282 cases have been registered under Drug (Prices Control) Order 1995, while 184 cases under the DPCO 2013.


    "These demand notices relate to a total amount of Rs 4,958.74 crore. Out of the total amount demanded so far, an amount of Rs 598.81 crore has been deposited by the companies to the government. An amount of Rs 3,460.32 crore is under litigation," Mandaviya said.


    He added that action for recovery of the overcharged amount is taken as per the provisions of Drug (Prices Control) Order 1995 and Drug (Prices Control) Order 2013.


    Set up in 1997, NPPA has been entrusted with the task of fixation/revision of prices of pharma products, enforcement of provisions of the Drugs (Prices Control) Order and monitoring of prices of controlled and decontrolled drugs.

    DPCOdrug overchargingDrug Prices Control OrderMansukh L MandaviyaNational Pharmaceutical Pricing AuthorityNPPA
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok